Commonwealth Equity Services, LLC Alaunos Therapeutics, Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$0.04 - $0.13 $120 - $390	3,000 Added 6.17%	51,638 $4,000
Q3 2023 Oct 23, 2023	SELL	$0.12 - $0.5 $8,127 - $33,864	-67,729 Reduced 58.2%	48,638 $6,000
Q2 2023 Aug 10, 2023	SELL	$0.43 - $0.65 $377 - $570	-877 Reduced 0.75%	116,367 $59,000
Q1 2023 May 11, 2023	BUY	$0.46 - $0.81 $690 - $1,215	1,500 Added 1.3%	117,244 $73,000
Q4 2022 Feb 07, 2023	SELL	$0.5 - $261.0 $6,161 - $3.22 Million	-12,322 Reduced 9.62%	115,744 $75,000
Q2 2022 Jul 19, 2022	SELL	$0.41 - $1.24 $9,953 - $30,104	-24,278 Reduced 15.94%	128,066 $158,000
Q1 2022 May 04, 2022	SELL	$0.62 - $1.17 $3,875 - $7,312	-6,250 Reduced 3.94%	152,344 $99,000
Q4 2021 Jan 31, 2022	BUY	$1.09 - $1.89 $11,911 - $20,653	10,928 Added 7.4%	158,594 $172,000
Q3 2021 Oct 29, 2021	BUY	$1.44 - $2.73 $117,177 - $222,148	81,373 Added 122.75%	147,666 $268,000
Q2 2021 Aug 11, 2021	BUY	$2.63 - $3.67 $55,427 - $77,345	21,075 Added 46.61%	66,293 $175,000
Q1 2021 May 04, 2021	SELL	$2.82 - $5.6 $60,074 - $119,296	-21,303 Reduced 32.02%	45,218 $162,000
Q4 2020 Feb 11, 2021	BUY	$2.09 - $3.09 $41,695 - $61,645	19,950 Added 42.84%	66,521 $167,000
Q3 2020 Nov 05, 2020	BUY	$2.39 - $3.43 $12,189 - $17,493	5,100 Added 12.3%	46,571 $117,000
Q2 2020 Aug 12, 2020	SELL	$2.2 - $3.71 $2,200 - $3,710	-1,000 Reduced 2.35%	41,471 $136,000
Q1 2020 May 11, 2020	SELL	$1.9 - $4.98 $530 - $1,389	-279 Reduced 0.65%	42,471 $104,000
Q4 2019 Feb 05, 2020	SELL	$3.95 - $5.35 $25,453 - $34,475	-6,444 Reduced 13.1%	42,750 $201,000
Q3 2019 Oct 30, 2019	SELL	$4.13 - $6.94 $16,107 - $27,066	-3,900 Reduced 7.35%	49,194 $210,000
Q2 2019 Jul 19, 2019	SELL	$3.98 - $6.2 $18,208 - $28,365	-4,575 Reduced 7.93%	53,094 $309,000
Q1 2019 May 13, 2019	SELL	$2.0 - $4.4 $11,960 - $26,312	-5,980 Reduced 9.4%	57,669 $222,000
Q4 2018 Feb 11, 2019	SELL	$1.61 - $3.62 $800 - $1,799	-497 Reduced 0.77%	63,649 $119,000
Q3 2018 Nov 06, 2018	BUY	$2.26 - $3.27 $4,135 - $5,984	1,830 Added 2.94%	64,146 $205,000
Q2 2018 Jul 31, 2018	BUY	$3.02 - $4.94 $13,710 - $22,427	4,540 Added 7.86%	62,316 $188,000
Q1 2018 May 14, 2018	BUY	$3.46 - $5.14 $69 - $102	20 Added 0.03%	57,776 $226,000
Q4 2017 Feb 12, 2018	BUY	$4.0 - $6.54 $231,024 - $377,724	57,756	57,756 $239,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account